Success Stories

Event Videos

Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate http://www.ncbi.nlm.nih.gov/pubmed/25716872 Gonzales E, Grosse B, Schuller B, Davit-Spraul A, Conti F, Guettier C, Cassio D, Jacquemin E. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate. Hepatology. 2015 Aug; 62(2):558-66. Abstract Published on: Aug-2015 Read more	Biliary Atresia Is Associated With Hypertension http://www.ncbi.nlm.nih.gov/pubmed/25651486 - billiary atresia Matloff RG, Diamond R, Weinberg A, Arnon R, Saland JM. Biliary Atresia Is Associated With Hypertension. J Pediatr Gastroenterol Nutr. 2015 Aug; 61(2):182-6. Abstract OBJECTIVES: Published on: Aug-2015 Read more
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus http://www.ncbi.nlm.nih.gov/pubmed/25851052 - hepatitis b Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, Hu JJ, Lin HH, Zhao LL, Mu SC, Lai MW, Lee CL, Lin HM, Tsai MS, Hsu JJ, Chen DS, Chan KA, Chang MH; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study); Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV PreMIT Study. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015 Aug; 62(2):375-86. Abstract Published on: Aug-2015 Read more	Biliary Atresia: Clinical Lessons Learned http://www.ncbi.nlm.nih.gov/pubmed/25658057 - billiary atresia Feldman AG, Mack CL. Biliary Atresia: Clinical Lessons Learned. J Pediatr Gastroenterol Nutr. 2015 Aug; 61(2):167-75. Abstract Published on: Aug-2015 Read more
Cognitive function and endogenous cytokine levels in children with chronic hepatitis C http://www.ncbi.nlm.nih.gov/pubmed/25496114 - hepatitis c Abu Faddan NH, Shehata GA, Abd Elhafeez HA, Mohamed AO, Hassan HS, Abd El Sameea F. Cognitive function and endogenous cytokine levels in children with chronic hepatitis C. J Viral Hepat. 2015 Aug; 22(8):665-70. Abstract Published on: Aug-2015 Read more	Fellow patients to share rare drug with Pakistan teenager Sun, 30 Aug 2015 Aayushi Pratap htmetro@hindustantimes.com Fellow patients to share rare drug with Pakistan teenager A group of patients, who attended a gathering on Wilson’s Disease at the Tata Memorial Hospital, have volunteered to give her (Saba Ahmed) the tablets after learning about her struggles. DR ABHA NAGRAL MUMBAI: Doctors at Jaslok Hospital, Peddar Road, will finally be able to give Pakistan citizen Saba Ahmed a new drug after she was unable to tolerate the standard drug given to most Wilson’s Disease patients. Read more
Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases http://www.ncbi.nlm.nih.gov/pubmed/26121376 . Hepatitis b Belle A, Baumann C, Bigard MA, Zallot C, Gizard E, Guéant JL, Bronowicki JP, Peyrin-Biroulet L. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases. Eur J Gastroenterol Hepatol. 2015 Aug; 27(8):877-81. Abstract BACKGROUND AND AIMS: Published on: Aug-2015 Read more	Pak girl’s health improving, attends support group meet \| Press Coverage August 30, 2015 Source/ Reference : http://timesofindia.indiatimes.com/city/mumbai/Pak-girls-health-improvin... TNN \| Aug 30, 2015 Mumbai: Saba Ahmed, the 15-year-old Pakistani girl who was rushed to Mumbai due to complications of a rare genetic disorder, was well enough within a week to attend a support group meeting on Saturday. Ordinary Mumbaikars raised over Rs 3.5 lakh through a crowd-funding effort to help the teenager fly into Mumbai last week from Karachi for treatment of Wilson's Disease. Her mother Nazia said, "We found out she had Wilson's disease 18 months ago. When doctors back home told me that Saba would never again speak or walk, we came to Mumbai." Read more
Difficulty Achieving Vitamin D Sufficiency With High-Dose Oral Repletion Therapy in Infants With Cholestasis http://www.ncbi.nlm.nih.gov/pubmed/25651487 .- neonatal cholestasis Jensen M, Abu-El-Haija M, Bishop W, Rahhal RM. Difficulty Achieving Vitamin D Sufficiency With High-Dose Oral Repletion Therapy in Infants With Cholestasis. J Pediatr Gastroenterol Nutr. 2015 Aug; 61(2):187-9. Abstract OBJECTIVES: Oral high-dose repletion vitamin D therapy, also known as stoss therapy, can be effective in the treatment of nutritional vitamin D deficiency rickets in infants and young children without liver disease and in patients with cystic fibrosis. There is no literature about this approach in infants with new-onset cholestasis. METHODS: Published on: Aug-2015 Read more	Efficacy of rifaximin on circulating endotoxins and cytokines in patients with non-alcoholic fatty liver disease http://www.ncbi.nlm.nih.gov/pubmed/26043290 Gangarapu V, Ince AT, Baysal B, Kayar Y, Kılıç U, Gök Ö, Uysal Ö, Şenturk H. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015 Jul;27(7):840-5. Abstract OBJECTIVE: Recent studies have suggested that endotoxin-induced cytokines play an important role in nonalcoholic fatty liver disease (NAFLD). Rifaximin is a nonabsorbable antibiotic that might act on Gram-negative bacteria, thereby inhibiting endotoxin proinflammatory cytokine production in patients with NAFLD. Our aim was to investigate the efficacy of rifaximin on NAFLD. METHODS: Published on: Jul-2015 Read more

CLF Intro movie

SMS requests to

9224791366

Ask The Expert

Pediatric Liver Specialists in India

Centres offering Genetic Testing for Pediatric Liver Diseases

Financial Aid Offered by Trusts

Follow us on:

Facebook Twitter YouTube